Detalles de la búsqueda
1.
Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma.
World J Surg Oncol
; 22(1): 117, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698475
2.
The impact of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection.
Hepatobiliary Pancreat Dis Int
; 22(4): 366-372, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35466065
3.
Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?
BMC Gastroenterol
; 20(1): 139, 2020 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375660
4.
HBeAg-negative chronic hepatitis patients should be monitored more strictly: a cross-sectional retrospective study on antiviral treatment-naïve patients.
J Med Virol
; 87(10): 1682-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25965250
5.
Hepatitis B surface antigen in late hepatitis B infection.
J Med Virol
; 87(3): 380-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25604455
6.
Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.
BMC Gastroenterol
; 14: 145, 2014 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25128299
7.
Diagnostic value of liver stiffness measurement combined with risk scores for esophagogastric variceal bleeding in patients with hepatitis B cirrhosis.
Eur J Radiol
; 173: 111385, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377895
8.
A novel small-animal locomotor activity recording device for biological clock research.
Animal Model Exp Med
; 7(1): 71-76, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38375555
9.
[Anti-fibrosis effects of fenofibrate in mice with hepatic fibrosis].
Zhonghua Gan Zang Bing Za Zhi
; 21(12): 914-9, 2013 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-24636293
10.
[Hepatitis B surface antigen affects the expression of lipid metabolism-related genes in HepG2 cells].
Zhonghua Gan Zang Bing Za Zhi
; 21(8): 624-30, 2013 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-24119745
11.
Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients.
World J Hepatol
; 15(8): 964-972, 2023 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37701915
12.
Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase.
J Clin Transl Hepatol
; 11(4): 817-826, 2023 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408816
13.
[Prolonged duration of the routine pegylated-interferon alfa-2a therapy produces superior virological response in HBeAg-positive chronic hepatitis B patients: a single-center cohort study].
Zhonghua Gan Zang Bing Za Zhi
; 20(10): 737-41, 2012 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-23207332
14.
[Relationship between the changes in immune cells and HBeAg loss following antiviral treatment in chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 20(11): 801-6, 2012 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-23206296
15.
[Relation between HBsAg levels during the immune clearance phase of hepatitis B virus infection and liver pathological stages of chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 20(10): 746-50, 2012 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-23207334
16.
Gasdermin D Inhibitor Necrosulfonamide Alleviates Lipopolysaccharide/D-galactosamine-induced Acute Liver Failure in Mice.
J Clin Transl Hepatol
; 10(6): 1148-1154, 2022 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36381100
17.
Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.
World J Gastroenterol
; 28(35): 5188-5202, 2022 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36188719
18.
[Retracted] Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells.
Mol Med Rep
; 23(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33846804
19.
Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease.
World J Gastroenterol
; 27(34): 5753-5763, 2021 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34629799
20.
Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection.
World J Gastroenterol
; 27(4): 336-344, 2021 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33584066